Daniel Brennan's Trading History
| VRTXVertex Pharmaceuticals | Oct 22, 2026 | Director | Uninformative Buy | 400.26K | $444.31K | |
| MDGLMadrigal Pharmaceuticals | Jun 18, 2026 | Director | Uninformative Buy | ― | $590.02K | |
| WATWaters | Feb 27, 2026 | Director | Uninformative Buy | ― | $626.99K | |
| BSXBoston Scientific | Feb 19, 2025 | EVP & CFO | Uninformative Buy | 1.55M | $9.48M | |
| NUANNuance Communications | Mar 04, 2022 | ― | Uninformative Sell | ― | $0.00 |
You May Also Like
Daniel Brennan insider profile FAQ
What is the percentage of profitable transactions made by Daniel Brennan?
The percentage of profitable transactions made by Daniel Brennan is 0%.
What is the average return per transaction made by Daniel Brennan?
The average return per transaction made by Daniel Brennan is -42.50%.
What stocks does Daniel Brennan hold?
Daniel Brennan holds: VRTX, BSX, NUAN, MDGL, WAT stocks.
What was Daniel Brennan’s latest transaction?
Daniel Brennan’s latest transaction was an Uninformative Buy of $400.26K.
What was Daniel Brennan's most profitable transaction?
Daniel Brennan’s most profitable transaction was an Informative Sell of BSX stock on February 26, 2014. The return on the trade was -26.00%.
What is Daniel Brennan's role in Vertex Pharmaceuticals?
Daniel Brennan's role in Vertex Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.